Results 51 to 60 of about 18,807 (230)

Bee products as alternatives in the treatment of viral infections

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract Medicines used in the treatment of viral infections usually reduce symptoms. There is a need to develop drugs that inhibit the viruses and do not merely relieve the symptoms. Natural bee products possess many pharmacological properties and are widely used in folk medicine. There are many studies on the antibacterial effects of bee products but
Michał Otręba   +3 more
wiley   +1 more source

COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Alopecia areata (AA) is a common non‐scarring alopecia. Data continue to emerge on associations with autoimmune and other conditions. Janus kinase inhibitors (JAKi) are increasingly used to treat AA. Objectives The aim was to assess variation in laboratory testing in patients with AA among hair experts internationally and to compare
Cathal O'Connor   +39 more
wiley   +1 more source

A persistent outbreak of varicella in a primary school in Dongguan City, Guangdong Province, China

open access: yesJournal of International Medical Research, 2020
Objectives To describe the epidemiological features of a school varicella outbreak in Dongguan City, China, to identify the reasons underlying persistent spread, and to assess the effectiveness of the varicella vaccine.
Jian-ming Zhong   +7 more
doaj   +1 more source

The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies

open access: yesClinicoEconomics and Outcomes Research, 2020
C Azzari,1 V Baldo,2 S Giuffrida,3 R Gani,4 E O’Brien,5 C Alimenti,6 VJ Daniels,7 LJ Wolfson7 1Department of Health Sciences, University of Florence and Meyer Children’s University Hospital, Florence 50139, Italy; 2Hygiene and Public Health ...
Azzari C   +7 more
doaj  

Immunogenicity of Varicella-Zoster Virus Glycoprotein E Formulated with Lipid Nanoparticles and Nucleic Immunostimulators in Mice

open access: yesVaccines, 2021
Theoretically, the subunit herpes zoster vaccine ShingrixTM could be used as a varicella vaccine that avoids the risk of developing shingles from vaccination, but bedside mixing strategies and the limited supply of the adjuvant component QS21 have made ...
Han Cao   +3 more
doaj   +1 more source

Cutaneous Vasculitis as a Covid‐19 Manifestation: A Cross‐Sectional Study With Detailed Histopathological Evaluation

open access: yesJEADV Clinical Practice, EarlyView.
Multiple cutaneous manifestations have been linked with COVID‐19, including cutaneous vasculitis, ranging from mild or asymptomatic to fulminant. We conducted a comprehensive study investigating the cutaneous and histopathological manifestations of vasculitis in 33 patients with COVID‐19.
Reem Diab   +8 more
wiley   +1 more source

Optimizing Varicella Vaccination Strategy: A Study on Age and Dose Impacts on Antibody Levels

open access: yesVaccines
Seropositivity study of Varicella in Healthy Populations in Guangzhou, China. Infection with varicella-zoster virus (VZV) leads to skin and mucous membranes blisters and the complications can be life threatening.
Qing He   +4 more
doaj   +1 more source

Varicella vaccination - the global experience [PDF]

open access: yesExpert Review of Vaccines, 2017
Varicella, although a frequently benign childhood disease, nevertheless represents a considerable health burden. WHO recommends including varicella vaccines in universal routine vaccination programs, and maintaining coverage >80%. Many countries have successfully introduced varicella vaccination and have benefited from lower disease burden, but many ...
Wutzler P   +5 more
openaire   +3 more sources

Live Attenuated Varicella Vaccine

open access: yesThe Journal of Pediatrics, 1985
Live attenuated varicella vaccine will in all probability soon be licensed in the United States for immunization of healthy children and adults and certain immunocompromised children. This vaccine can be expected to protect susceptibles from varicella (or to modify it) in those subsequently exposed to the wild virus.
openaire   +12 more sources

Expert Perspective: Hematologic Malignancies and Vasculitis

open access: yes
Arthritis &Rheumatology, EarlyView.
Michelle L. Robinette, Hetty E. Carraway
wiley   +1 more source

Home - About - Disclaimer - Privacy